Autopsy report · NCT06619015

Tailoring Obesity Treatment Trial

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“suspended by the danish medical agency”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2, Phase 3
Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark
Sponsor type: University, hospital or other
Conditions: Obesity; Appetite Regulation; PreDiabetes
Interventions: Pramlintide Acetate 1 MG/ML; Semaglutide Pen Injector; Sodium Chloride 0.9% Inj
Participants: 0
Sites: 1
Countries: Denmark

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.